Emergent BioSolutions Ratios (2010-2026) | EBS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	78.43%	87.15%	99.75%	73.65%	67.11%	38.64%	49.33%	6.94%	43.59%	34.64%	33.08%	51.86%		58.27%	39.39%	60.17%	52.52%	62.83%	42.91%	53.88%
EBT Margin (Quarter)	1.91%	-15.89%	34.97%	-1.25%	-34.13%	-28.01%	-18.59%	-97.75%	-74.05%	-98.30%	-19.70%	4.03%	-539.60%	48.47%	-14.18%	41.72%	-11.92%	24.92%	-34.10%	8.58%
EBIT Margin (Quarter)	1.88%	-15.61%	39.13%	2.26%	-31.45%	-18.88%	-16.75%	-89.84%	-86.68%	-89.50%	-15.84%	13.25%	-407.00%	21.95%	-4.88%	22.46%	1.14%	33.10%	-18.76%	6.73%
EBITDA Margin (Quarter)	1.88%	-15.61%	39.13%	2.26%	-31.45%	-18.88%	-16.75%	-89.84%	-86.68%	-89.50%	-15.84%	13.25%	-407.00%	21.95%	-4.88%	22.46%	1.14%	33.10%	-18.76%	6.73%
Operating Margin (Quarter)	1.88%	-15.61%	39.13%	2.26%	-31.45%	-18.88%	-16.75%	-89.84%	-86.68%	-89.50%	-15.84%	13.25%	-407.00%	21.95%	-4.88%	22.46%	1.14%	33.10%	-18.76%	6.73%
Net Margin (Quarter)	1.22%	-11.42%	24.27%	-1.21%	-23.25%	-36.31%	-20.29%	-113.33%	-77.36%	-97.38%	-17.90%	3.00%	-566.20%	39.07%	-16.08%	30.60%	-8.52%	22.15%	-36.72%	4.36%
FCF Margin (Quarter)	-7.66%	16.91%	42.04%	-22.80%	-19.66%	-42.48%	53.18%	-116.74%	-39.72%	28.98%	-3.72%	-21.94%	70.80%	50.34%	-41.91%	-6.66%	73.46%	1.04%	52.39%	-23.19%
Efficiency
Inventory Average (Quarter)	396.45M	375.50M	354.55M	372.60M	413.10M	476.85M	439.45M	359.30M	361.10M	354.20M	341.50M	331.15M	325.45M	320.10M	317.20M	312.85M	326.30M	347.45M	349.85M	335.50M
Assets Average (Quarter)	2,907.65M	2,891.35M	2,912.60M	2,869.05M	2,757.90M	2,815.55M	3,031.00M	3,058.05M	2,564.30M	2,035.95M	1,858.15M	1,813.40M	1,658.55M	1,495.65M	1,433.75M	1,407.90M	1,421.60M	1,439.05M	1,389.80M	1,319.50M
Invested Capital (Quarter)
Asset Utilization Ratio (Quarter)	0.59	0.56	0.61	0.59	0.57	0.54	0.37	0.32	0.42	0.54	0.56	0.65	0.54	0.62	0.59	0.54	0.60	0.55	0.53	0.51
Leverage & Solvency
Interest Coverage Ratio (Quarter)	0.83	-5.32	39.83	0.59	-9.78	-5.33	-4.32	-6.83	-10.24	-12.29	-2.02	1.64	-8.62	7.77	-0.64	2.99	0.05	5.03	-1.59	0.80
Debt Ratio (Quarter)	0.30	0.30	0.29	0.30	0.30	0.36	0.14	0.15	0.42	0.24	0.24	0.50	0.57	0.47	0.48	0.47	0.49	0.47	0.43	0.43
Times Interest Earned (Quarter)	0.83	-5.32	39.83	0.59	-9.78	-5.33	-4.32	-6.83	-10.24	-12.29	-2.02	1.64	-8.62	7.77	-0.64	2.99	0.05	5.03	-1.59	0.80
Valuation
Enterprise Value (Quarter)	-447.70M	-404.00M	-576.30M	-436.00M	-358.30M	-241.00M	-642.60M	-430.20M	-88.60M	-87.80M	-111.70M	-79.00M	-71.00M	-156.40M	-105.60M	-152.80M	-271.00M	-249.20M	-209.10M	-161.50M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	-0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	16.55%	12.38%	13.45%	9.78%	6.96%	6.75%	-9.43%	-17.61%	-28.92%	-53.78%	-60.19%	-45.55%	-43.28%	-11.30%	-8.55%	-7.61%	8.23%	9.10%	7.96%	5.18%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Emergent BioSolutions Ratios (2010-2026) | EBS

Research Tools

Developers

Emergent BioSolutions Ratios (2010-2026) | EBS

Create an account

Sign In

Reset Password